ACT Dry Mouth Lozenges
Allegations: Failing to disclose that the product is detrimental to oral health due to having a pH level that is below the pH level of tooth enamel and root dentin
Sherwood et al. v. Chattem, Inc.
23-cv-3980, S.D.N.Y.
(May 2023)
Cortizone-10 hydrocortisone topical creams, ointments, gels, lotions, and liquids
Misleadingly marketing 1% hydrocortisone products as “Maximum Strength” when there are products with stronger dosages available
Pending
Allegations: Failing to disclose that the product is detrimental to oral health due to having a pH level that is below the pH level of tooth enamel and root dentin
Allegations: False natural claims
Allegations: False natural claims
In July 2013, a federal judge granted final approval of a settlement agreement reached in a false advertising class-action lawsuit against Chattem, Inc. The complaint, which was originally filed in…
May 2015: A federal judge granted Chattem Inc.’s motion to dismiss finding that the claim was preempted by federal law. February 2015: A false advertising class-action lawsuit was filed against…
February 2015: This action was dismissed for lack of subject matter jurisdiction. The dismissal was When a complaint is dismissed without prejudice, an amended version of the complaint can be…
TINA.org investigates after doctor challenges pain reliever’s “clinically proven” labeling claim on Twitter.
NAD tells marketer to watch its mouth when it comes to making certain dry mouth product claims.
Makers of nasal allergy spray told to cease consumer preference claims.